Linda Ficociello

Joslin Diabetes Center

Papers

1

Total Citations

41

H-Index

1

About

Dr. Linda Ficociello is a distinguished researcher in nephrology and diabetes, whose work has significantly advanced the understanding of renal decline in type 1 diabetes. Her key research areas include biomarker discovery for diabetic kidney disease, with a focus on the kallikrein-kinin system. Her most-cited study, "Plasma kininogen and kininogen fragments are biomarkers of progressive renal decline in type 1 diabetes" (2013, 41 citations), identified novel plasma biomarkers that predict progressive kidney function loss, offering a critical tool for early intervention. This contribution has shaped clinical approaches to monitoring renal health in diabetic patients, highlighting the role of kininogen fragments as sensitive indicators of disease progression. Dr. Ficociello’s work bridges molecular pathology and clinical practice, providing insights that may guide personalized treatment strategies. Her research has been instrumental in advancing the field of diabetic nephropathy, earning recognition for its translational impact. Through her dedication, she continues to inspire students and researchers exploring the intersection of metabolism and renal disease.

Research Focus

Key Achievements

1
H-Index
1
Papers
41
Total Citations
41
Avg Citations/Paper
🏆 Most Cited Paper
Plasma kininogen and kininogen fragments are biomarkers of progressive renal decline in type 1 diabetes
41 citations · 2013
📈 Most Prolific Year: 2013 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Joslin Diabetes Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago